165 related articles for article (PubMed ID: 14560310)
21. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.
Au CG; Butler TL; Egan JR; Cooper ST; Lo HP; Compton AG; North KN; Winlaw DS
Acta Neuropathol; 2008 Sep; 116(3):235-46. PubMed ID: 18392839
[TBL] [Abstract][Full Text] [Related]
22. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.
Paradas C; Llauger J; Diaz-Manera J; Rojas-García R; De Luna N; Iturriaga C; Márquez C; Usón M; Hankiewicz K; Gallardo E; Illa I
Neurology; 2010 Jul; 75(4):316-23. PubMed ID: 20574037
[TBL] [Abstract][Full Text] [Related]
23. Loss of podocyte dysferlin expression is associated with minimal change nephropathy.
Izzedine H; Brocheriou I; Eymard B; Le Charpentier M; Romero NB; Lenaour G; Bourry E; Deray G
Am J Kidney Dis; 2006 Jul; 48(1):143-50. PubMed ID: 16797397
[TBL] [Abstract][Full Text] [Related]
24. From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis.
Klinge L; Laval S; Keers S; Haldane F; Straub V; Barresi R; Bushby K
FASEB J; 2007 Jun; 21(8):1768-76. PubMed ID: 17363620
[TBL] [Abstract][Full Text] [Related]
25. Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies.
Cagliani R; Magri F; Toscano A; Merlini L; Fortunato F; Lamperti C; Rodolico C; Prelle A; Sironi M; Aguennouz M; Ciscato P; Uncini A; Moggio M; Bresolin N; Comi GP
Hum Mutat; 2005 Sep; 26(3):283. PubMed ID: 16100712
[TBL] [Abstract][Full Text] [Related]
26. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.
Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y
FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392
[TBL] [Abstract][Full Text] [Related]
27. Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice.
Leriche-Guérin K; Anderson LV; Wrogemann K; Roy B; Goulet M; Tremblay JP
Neuromuscul Disord; 2002 Feb; 12(2):167-73. PubMed ID: 11738359
[TBL] [Abstract][Full Text] [Related]
28. SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression.
Vieira NM; Bueno CR; Brandalise V; Moraes LV; Zucconi E; Secco M; Suzuki MF; Camargo MM; Bartolini P; Brum PC; Vainzof M; Zatz M
Stem Cells; 2008 Sep; 26(9):2391-8. PubMed ID: 18583542
[TBL] [Abstract][Full Text] [Related]
29. Characterization of mouse myotilin and its promoter.
Mologni L; Moza M; Lalowski MM; Carpén O
Biochem Biophys Res Commun; 2005 Apr; 329(3):1001-9. PubMed ID: 15752755
[TBL] [Abstract][Full Text] [Related]
30. Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.
Tagawa K; Ogawa M; Kawabe K; Yamanaka G; Matsumura T; Goto K; Nonaka I; Nishino I; Hayashi YK
J Neurol Sci; 2003 Jul; 211(1-2):23-8. PubMed ID: 12767493
[TBL] [Abstract][Full Text] [Related]
31. A case of dysferlinopathy presenting choreic movements.
Takahashi T; Aoki M; Imai T; Yoshioka M; Konno H; Higano S; Onodera Y; Saito H; Kimura I; Itoyama Y
Mov Disord; 2006 Sep; 21(9):1513-5. PubMed ID: 16817213
[TBL] [Abstract][Full Text] [Related]
32. Miyoshi myopathy patients with novel 5' splicing donor site mutations showed different dysferlin immunostaining at the sarcolemma.
Saito A; Higuchi I; Nakagawa M; Saito M; Hirata K; Suehara M; Yoshida Y; Takahashi T; Aoki M; Osame M
Acta Neuropathol; 2002 Dec; 104(6):615-20. PubMed ID: 12410383
[TBL] [Abstract][Full Text] [Related]
33. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).
Weiler T; Bashir R; Anderson LV; Davison K; Moss JA; Britton S; Nylen E; Keers S; Vafiadaki E; Greenberg CR; Bushby CR; Wrogemann K
Hum Mol Genet; 1999 May; 8(5):871-7. PubMed ID: 10196377
[TBL] [Abstract][Full Text] [Related]
34. The third human FER-1-like protein is highly similar to dysferlin.
Britton S; Freeman T; Vafiadaki E; Keers S; Harrison R; Bushby K; Bashir R
Genomics; 2000 Sep; 68(3):313-21. PubMed ID: 10995573
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the DYSF mutational spectrum in a large cohort of patients.
Krahn M; Béroud C; Labelle V; Nguyen K; Bernard R; Bassez G; Figarella-Branger D; Fernandez C; Bouvenot J; Richard I; Ollagnon-Roman E; Bevilacqua JA; Salvo E; Attarian S; Chapon F; Pellissier JF; Pouget J; Hammouda el H; Laforêt P; Urtizberea JA; Eymard B; Leturcq F; Lévy N
Hum Mutat; 2009 Feb; 30(2):E345-75. PubMed ID: 18853459
[TBL] [Abstract][Full Text] [Related]
36. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B.
Bittner RE; Anderson LV; Burkhardt E; Bashir R; Vafiadaki E; Ivanova S; Raffelsberger T; Maerk I; Höger H; Jung M; Karbasiyan M; Storch M; Lassmann H; Moss JA; Davison K; Harrison R; Bushby KM; Reis A
Nat Genet; 1999 Oct; 23(2):141-2. PubMed ID: 10508505
[No Abstract] [Full Text] [Related]
37. Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.
Kesper K; Kornblum C; Reimann J; Lutterbey G; Schröder R; Wattjes MP
Acta Neurol Scand; 2009 Aug; 120(2):111-8. PubMed ID: 19154541
[TBL] [Abstract][Full Text] [Related]
38. AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration.
Huang Y; Laval SH; van Remoortere A; Baudier J; Benaud C; Anderson LV; Straub V; Deelder A; Frants RR; den Dunnen JT; Bushby K; van der Maarel SM
FASEB J; 2007 Mar; 21(3):732-42. PubMed ID: 17185750
[TBL] [Abstract][Full Text] [Related]
39. Private dysferlin exon skipping mutation (c.5492G>A) with a founder effect reveals further alternative splicing involving exons 49-51.
Santos R; Oliveira J; Vieira E; Coelho T; Carneiro AL; Evangelista T; Dias C; Fortuna A; Geraldo A; Negrão L; Guimarães A; Bronze-da-Rocha E
J Hum Genet; 2010 Aug; 55(8):546-9. PubMed ID: 20535123
[TBL] [Abstract][Full Text] [Related]
40. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis.
Lo HP; Cooper ST; Evesson FJ; Seto JT; Chiotis M; Tay V; Compton AG; Cairns AG; Corbett A; MacArthur DG; Yang N; Reardon K; North KN
Neuromuscul Disord; 2008 Jan; 18(1):34-44. PubMed ID: 17897828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
